APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Influenza Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Influenza Drugs Market Analysis and Forecast 2026-2032

Report ID 174002660220 December 2025209 pages

Choose your research edition.

Industry ResearchInfluenza Drugs Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza Drugs Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Influenza Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza Drugs Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Influenza Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Influenza Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Influenza Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Influenza Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Influenza Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Influenza Drugs include Novartis, Roche, Eli Lilly, Pfizer, GlaxoSmithKline, Bayer, AstraZeneca, Serum Institute of India and Seqirus, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Influenza Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Influenza Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Influenza Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Influenza Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Influenza Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Influenza Drugs sales, projected growth trends, production technology, application and end-user industry.

Influenza Drugs Segment by Company

Novartis

Roche

Eli Lilly

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

Serum Institute of India

Seqirus

Sanofi Pasteur

Protein Sciences Corporation

Emergent Biosolutions

Celgene

Bristol-Myers Squibb]

BioCryst Pharmaceuticals

Alvogen

Influenza Drugs Segment by Type

Oseltamivir Phosphate

Peramivir

Zanamivir

Other Influenza Drugs

Influenza Drugs Segment by Application

Adults

Chidren

Influenza Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Influenza Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Influenza Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Influenza Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Influenza Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oseltamivir Phosphate Major Manufacturers Table 3. Peramivir Major Manufacturers Table 4. Zanamivir Major Manufacturers Table 5. Other Influenza Drugs Major Manufacturers Table 6. Global Influenza Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Adults Major Manufacturers Table 8. Chidren Major Manufacturers Table 9. Influenza Drugs Industry Trends Table 10. Influenza Drugs Industry Drivers Table 11. Influenza Drugs Industry Opportunities and Challenges Table 12. Influenza Drugs Industry Restraints Table 13. Global Influenza Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Influenza Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Influenza Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Influenza Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Influenza Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Influenza Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Tons) Table 19. Global Influenza Drugs Sales by Region (2021-2026) & (K Tons) Table 20. Global Influenza Drugs Sales by Region (2027-2032) & (K Tons) Table 21. Global Influenza Drugs Sales Market Share by Region (2021-2026) Table 22. Global Influenza Drugs Sales Market Share by Region (2027-2032) Table 23. Global Influenza Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Influenza Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Influenza Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Influenza Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Influenza Drugs Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 28. Global Influenza Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Influenza Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Influenza Drugs Manufacturers, Product Type & Application Table 31. Global Influenza Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Influenza Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Influenza Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Influenza Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Influenza Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Influenza Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Influenza Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Influenza Drugs Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 40. Global Influenza Drugs Sales by Type (2021-2026) & (K Tons) Table 41. Global Influenza Drugs Sales by Type (2027-2032) & (K Tons) Table 42. Global Influenza Drugs Sales Market Share by Type (2021-2026) Table 43. Global Influenza Drugs Sales Market Share by Type (2027-2032) Table 44. Global Influenza Drugs Price by Type (2021-2026) & (US$/Ton) Table 45. Global Influenza Drugs Price by Type (2027-2032) & (US$/Ton) Table 46. Global Influenza Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Influenza Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Influenza Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Influenza Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Influenza Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Influenza Drugs Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 52. Global Influenza Drugs Sales by Application (2021-2026) & (K Tons) Table 53. Global Influenza Drugs Sales by Application (2027-2032) & (K Tons) Table 54. Global Influenza Drugs Sales Market Share by Application (2021-2026) Table 55. Global Influenza Drugs Sales Market Share by Application (2027-2032) Table 56. Global Influenza Drugs Price by Application (2021-2026) & (US$/Ton) Table 57. Global Influenza Drugs Price by Application (2027-2032) & (US$/Ton) Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Novartis Influenza Drugs Product Portfolio Table 62. Novartis Recent Development Table 63. Roche Company Information Table 64. Roche Business Overview Table 65. Roche Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Roche Influenza Drugs Product Portfolio Table 67. Roche Recent Development Table 68. Eli Lilly Company Information Table 69. Eli Lilly Business Overview Table 70. Eli Lilly Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Eli Lilly Influenza Drugs Product Portfolio Table 72. Eli Lilly Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Pfizer Influenza Drugs Product Portfolio Table 77. Pfizer Recent Development Table 78. GlaxoSmithKline Company Information Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline Influenza Drugs Product Portfolio Table 82. GlaxoSmithKline Recent Development Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Bayer Influenza Drugs Product Portfolio Table 87. Bayer Recent Development Table 88. AstraZeneca Company Information Table 89. AstraZeneca Business Overview Table 90. AstraZeneca Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. AstraZeneca Influenza Drugs Product Portfolio Table 92. AstraZeneca Recent Development Table 93. Serum Institute of India Company Information Table 94. Serum Institute of India Business Overview Table 95. Serum Institute of India Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Serum Institute of India Influenza Drugs Product Portfolio Table 97. Serum Institute of India Recent Development Table 98. Seqirus Company Information Table 99. Seqirus Business Overview Table 100. Seqirus Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Seqirus Influenza Drugs Product Portfolio Table 102. Seqirus Recent Development Table 103. Sanofi Pasteur Company Information Table 104. Sanofi Pasteur Business Overview Table 105. Sanofi Pasteur Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Sanofi Pasteur Influenza Drugs Product Portfolio Table 107. Sanofi Pasteur Recent Development Table 108. Protein Sciences Corporation Company Information Table 109. Protein Sciences Corporation Business Overview Table 110. Protein Sciences Corporation Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Protein Sciences Corporation Influenza Drugs Product Portfolio Table 112. Protein Sciences Corporation Recent Development Table 113. Emergent Biosolutions Company Information Table 114. Emergent Biosolutions Business Overview Table 115. Emergent Biosolutions Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Emergent Biosolutions Influenza Drugs Product Portfolio Table 117. Emergent Biosolutions Recent Development Table 118. Celgene Company Information Table 119. Celgene Business Overview Table 120. Celgene Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Celgene Influenza Drugs Product Portfolio Table 122. Celgene Recent Development Table 123. Bristol-Myers Squibb] Company Information Table 124. Bristol-Myers Squibb] Business Overview Table 125. Bristol-Myers Squibb] Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Bristol-Myers Squibb] Influenza Drugs Product Portfolio Table 127. Bristol-Myers Squibb] Recent Development Table 128. BioCryst Pharmaceuticals Company Information Table 129. BioCryst Pharmaceuticals Business Overview Table 130. BioCryst Pharmaceuticals Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. BioCryst Pharmaceuticals Influenza Drugs Product Portfolio Table 132. BioCryst Pharmaceuticals Recent Development Table 133. Alvogen Company Information Table 134. Alvogen Business Overview Table 135. Alvogen Influenza Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Alvogen Influenza Drugs Product Portfolio Table 137. Alvogen Recent Development Table 138. North America Influenza Drugs Revenue by Type (2021-2026) & (US$ Million) Table 139. North America Influenza Drugs Revenue by Type (2027-2032) & (US$ Million) Table 140. North America Influenza Drugs Sales by Type (2021-2026) & (K Tons) Table 141. North America Influenza Drugs Sales by Type (2027-2032) & (K Tons) Table 142. North America Influenza Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 143. North America Influenza Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 144. North America Influenza Drugs Revenue by Application (2021-2026) & (US$ Million) Table 145. North America Influenza Drugs Revenue by Application (2027-2032) & (US$ Million) Table 146. North America Influenza Drugs Sales by Application (2021-2026) & (K Tons) Table 147. North America Influenza Drugs Sales by Application (2027-2032) & (K Tons) Table 148. North America Influenza Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 149. North America Influenza Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 150. North America Influenza Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. North America Influenza Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. North America Influenza Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. North America Influenza Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 154. North America Influenza Drugs Sales by Country (2021-2026) & (K Tons) Table 155. North America Influenza Drugs Sales by Country (2027-2032) & (K Tons) Table 156. North America Influenza Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 157. North America Influenza Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 158. United States Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 159. Canada Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 160. Europe Influenza Drugs Revenue by Type (2021-2026) & (US$ Million) Table 161. Europe Influenza Drugs Revenue by Type (2027-2032) & (US$ Million) Table 162. Europe Influenza Drugs Sales by Type (2021-2026) & (K Tons) Table 163. Europe Influenza Drugs Sales by Type (2027-2032) & (K Tons) Table 164. Europe Influenza Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 165. Europe Influenza Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 166. Europe Influenza Drugs Revenue by Application (2021-2026) & (US$ Million) Table 167. Europe Influenza Drugs Revenue by Application (2027-2032) & (US$ Million) Table 168. Europe Influenza Drugs Sales by Application (2021-2026) & (K Tons) Table 169. Europe Influenza Drugs Sales by Application (2027-2032) & (K Tons) Table 170. Europe Influenza Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 171. Europe Influenza Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 172. Europe Influenza Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Europe Influenza Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. Europe Influenza Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. Europe Influenza Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 176. Europe Influenza Drugs Sales by Country (2021-2026) & (K Tons) Table 177. Europe Influenza Drugs Sales by Country (2027-2032) & (K Tons) Table 178. Europe Influenza Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 179. Europe Influenza Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 180. Germany Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 181. France Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 182. U.K. Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 183. Italy Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 184. Netherlands Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 185. China Influenza Drugs Revenue by Type (2021-2026) & (US$ Million) Table 186. China Influenza Drugs Revenue by Type (2027-2032) & (US$ Million) Table 187. China Influenza Drugs Sales by Type (2021-2026) & (K Tons) Table 188. China Influenza Drugs Sales by Type (2027-2032) & (K Tons) Table 189. China Influenza Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 190. China Influenza Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 191. China Influenza Drugs Revenue by Application (2021-2026) & (US$ Million) Table 192. China Influenza Drugs Revenue by Application (2027-2032) & (US$ Million) Table 193. China Influenza Drugs Sales by Application (2021-2026) & (K Tons) Table 194. China Influenza Drugs Sales by Application (2027-2032) & (K Tons) Table 195. China Influenza Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 196. China Influenza Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 197. Asia Influenza Drugs Revenue by Type (2021-2026) & (US$ Million) Table 198. Asia Influenza Drugs Revenue by Type (2027-2032) & (US$ Million) Table 199. Asia Influenza Drugs Sales by Type (2021-2026) & (K Tons) Table 200. Asia Influenza Drugs Sales by Type (2027-2032) & (K Tons) Table 201. Asia Influenza Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 202. Asia Influenza Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 203. Asia Influenza Drugs Revenue by Application (2021-2026) & (US$ Million) Table 204. Asia Influenza Drugs Revenue by Application (2027-2032) & (US$ Million) Table 205. Asia Influenza Drugs Sales by Application (2021-2026) & (K Tons) Table 206. Asia Influenza Drugs Sales by Application (2027-2032) & (K Tons) Table 207. Asia Influenza Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 208. Asia Influenza Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 209. Asia Influenza Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. Asia Influenza Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. Asia Influenza Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. Asia Influenza Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 213. Asia Influenza Drugs Sales by Country (2021-2026) & (K Tons) Table 214. Asia Influenza Drugs Sales by Country (2027-2032) & (K Tons) Table 215. Asia Influenza Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 216. Asia Influenza Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 217. Japan Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 218. South Korea Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 219. India Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 220. Australia Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 221. China Taiwan Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 222. Southeast Asia Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 223. SAMEA Influenza Drugs Revenue by Type (2021-2026) & (US$ Million) Table 224. SAMEA Influenza Drugs Revenue by Type (2027-2032) & (US$ Million) Table 225. SAMEA Influenza Drugs Sales by Type (2021-2026) & (K Tons) Table 226. SAMEA Influenza Drugs Sales by Type (2027-2032) & (K Tons) Table 227. SAMEA Influenza Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 228. SAMEA Influenza Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 229. SAMEA Influenza Drugs Revenue by Application (2021-2026) & (US$ Million) Table 230. SAMEA Influenza Drugs Revenue by Application (2027-2032) & (US$ Million) Table 231. SAMEA Influenza Drugs Sales by Application (2021-2026) & (K Tons) Table 232. SAMEA Influenza Drugs Sales by Application (2027-2032) & (K Tons) Table 233. SAMEA Influenza Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 234. SAMEA Influenza Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 235. SAMEA Influenza Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. SAMEA Influenza Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. SAMEA Influenza Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. SAMEA Influenza Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 239. SAMEA Influenza Drugs Sales by Country (2021-2026) & (K Tons) Table 240. SAMEA Influenza Drugs Sales by Country (2027-2032) & (K Tons) Table 241. SAMEA Influenza Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 242. SAMEA Influenza Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 243. Brazil Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 244. Argentina Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 245. Chile Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 246. Colombia Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 247. Peru Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 248. Saudi Arabia Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 249. Israel Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 250. UAE Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 251. Turkey Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 252. Iran Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 253. Egypt Influenza Drugs Revenue (2021-2032) & (US$ Million) Table 254. Key Raw Materials Table 255. Raw Materials Key Suppliers Table 256. Influenza Drugs Distributors List Table 257. Influenza Drugs Customers List Table 258. Research Programs/Design for This Report Table 259. Authors List of This Report Table 260. Secondary Sources Table 261. Primary Sources List of Figures Figure 1. Influenza Drugs Image Figure 2. Global Influenza Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Influenza Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oseltamivir Phosphate Image Figure 5. Peramivir Image Figure 6. Zanamivir Image Figure 7. Other Influenza Drugs Image Figure 8. Global Influenza Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Influenza Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Adults Image Figure 11. Chidren Image Figure 12. Global Influenza Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Influenza Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Influenza Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Influenza Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Influenza Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Influenza Drugs Sales (2021-2032) & (K Tons) Figure 18. Global Influenza Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 19. Global Influenza Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Influenza Drugs Sales YoY (2021-2032) & (K Tons) Figure 21. Europe Influenza Drugs Sales YoY (2021-2032) & (K Tons) Figure 22. China Influenza Drugs Sales YoY (2021-2032) & (K Tons) Figure 23. Asia (Excluding China) Influenza Drugs Sales YoY (2021-2032) & (K Tons) Figure 24. South America, Middle East and Africa Influenza Drugs Sales YoY (2021-2032) & (K Tons) Figure 25. Global Influenza Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Influenza Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Influenza Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Influenza Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Influenza Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Influenza Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 32. Global Influenza Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Influenza Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Influenza Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Influenza Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Influenza Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Influenza Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 38. Global Influenza Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Influenza Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Influenza Drugs Revenue Share by Type (2021-2032) Figure 41. North America Influenza Drugs Sales Share by Type (2021-2032) Figure 42. North America Influenza Drugs Revenue Share by Application (2021-2032) Figure 43. North America Influenza Drugs Sales Share by Application (2021-2032) Figure 44. North America Influenza Drugs Revenue Share by Country (2021-2032) Figure 45. North America Influenza Drugs Sales Share by Country (2021-2032) Figure 46. Europe Influenza Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Influenza Drugs Sales Share by Type (2021-2032) Figure 48. Europe Influenza Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Influenza Drugs Sales Share by Application (2021-2032) Figure 50. Europe Influenza Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Influenza Drugs Sales Share by Country (2021-2032) Figure 52. China Influenza Drugs Revenue Share by Type (2021-2032) Figure 53. China Influenza Drugs Sales Share by Type (2021-2032) Figure 54. China Influenza Drugs Revenue Share by Application (2021-2032) Figure 55. China Influenza Drugs Sales Share by Application (2021-2032) Figure 56. Asia Influenza Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Influenza Drugs Sales Share by Type (2021-2032) Figure 58. Asia Influenza Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Influenza Drugs Sales Share by Application (2021-2032) Figure 60. Asia Influenza Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Influenza Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Influenza Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Influenza Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Influenza Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Influenza Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Influenza Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Influenza Drugs Sales Share by Country (2021-2032) Figure 68. Influenza Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Influenza Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Oseltamivir Phosphate
  • Peramivir
  • Zanamivir
  • Other Influenza Drugs
Applications
  • Adults
  • Chidren
Companies covered
  • Novartis
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Serum Institute of India
  • Seqirus
  • Sanofi Pasteur
  • Protein Sciences Corporation
  • Emergent Biosolutions
  • Celgene
  • Bristol-Myers Squibb]
  • BioCryst Pharmaceuticals
  • Alvogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Influenza Drugs Market by Type
  3. 1.2.1 Global Influenza Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oseltamivir Phosphate
  5. 1.2.3 Peramivir
  6. 1.2.4 Zanamivir
  7. 1.2.5 Other Influenza Drugs
  8. 1.3 Influenza Drugs Market by Application
  9. 1.3.1 Global Influenza Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Adults
  11. 1.3.3 Chidren
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Influenza Drugs Market Dynamics
  1. 2.1 Influenza Drugs Industry Trends
  2. 2.2 Influenza Drugs Industry Drivers
  3. 2.3 Influenza Drugs Industry Opportunities and Challenges
  4. 2.4 Influenza Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Influenza Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Influenza Drugs Revenue by Region
  3. 3.2.1 Global Influenza Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Influenza Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Influenza Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Influenza Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Influenza Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Influenza Drugs Sales by Region
  9. 3.4.1 Global Influenza Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Influenza Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Influenza Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Influenza Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Influenza Drugs Revenue by Manufacturers
  2. 4.1.1 Global Influenza Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Influenza Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Influenza Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Influenza Drugs Sales by Manufacturers
  6. 4.2.1 Global Influenza Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Influenza Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Influenza Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Influenza Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Influenza Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Influenza Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Influenza Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Influenza Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Influenza Drugs Market CR5 and HHI
  16. 4.8.2 2025 Influenza Drugs Tier 1, Tier 2, and Tier 3
5 Influenza Drugs Market by Type
  1. 5.1 Global Influenza Drugs Revenue by Type
  2. 5.1.1 Global Influenza Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Influenza Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Influenza Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Influenza Drugs Sales by Type
  6. 5.2.1 Global Influenza Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Influenza Drugs Sales by Type (2021-2032) & (K Tons)
  8. 5.2.3 Global Influenza Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Influenza Drugs Price by Type
6 Influenza Drugs Market by Application
  1. 6.1 Global Influenza Drugs Revenue by Application
  2. 6.1.1 Global Influenza Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Influenza Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Influenza Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Influenza Drugs Sales by Application
  6. 6.2.1 Global Influenza Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Influenza Drugs Sales by Application (2021-2032) & (K Tons)
  8. 6.2.3 Global Influenza Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Influenza Drugs Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Influenza Drugs Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Roche
  8. 7.2.1 Roche Company Information
  9. 7.2.2 Roche Business Overview
  10. 7.2.3 Roche Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Roche Influenza Drugs Product Portfolio
  12. 7.2.5 Roche Recent Developments
  13. 7.3 Eli Lilly
  14. 7.3.1 Eli Lilly Company Information
  15. 7.3.2 Eli Lilly Business Overview
  16. 7.3.3 Eli Lilly Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly Influenza Drugs Product Portfolio
  18. 7.3.5 Eli Lilly Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Influenza Drugs Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 GlaxoSmithKline
  26. 7.5.1 GlaxoSmithKline Company Information
  27. 7.5.2 GlaxoSmithKline Business Overview
  28. 7.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GlaxoSmithKline Influenza Drugs Product Portfolio
  30. 7.5.5 GlaxoSmithKline Recent Developments
  31. 7.6 Bayer
  32. 7.6.1 Bayer Company Information
  33. 7.6.2 Bayer Business Overview
  34. 7.6.3 Bayer Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bayer Influenza Drugs Product Portfolio
  36. 7.6.5 Bayer Recent Developments
  37. 7.7 AstraZeneca
  38. 7.7.1 AstraZeneca Company Information
  39. 7.7.2 AstraZeneca Business Overview
  40. 7.7.3 AstraZeneca Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 AstraZeneca Influenza Drugs Product Portfolio
  42. 7.7.5 AstraZeneca Recent Developments
  43. 7.8 Serum Institute of India
  44. 7.8.1 Serum Institute of India Company Information
  45. 7.8.2 Serum Institute of India Business Overview
  46. 7.8.3 Serum Institute of India Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Serum Institute of India Influenza Drugs Product Portfolio
  48. 7.8.5 Serum Institute of India Recent Developments
  49. 7.9 Seqirus
  50. 7.9.1 Seqirus Company Information
  51. 7.9.2 Seqirus Business Overview
  52. 7.9.3 Seqirus Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Seqirus Influenza Drugs Product Portfolio
  54. 7.9.5 Seqirus Recent Developments
  55. 7.10 Sanofi Pasteur
  56. 7.10.1 Sanofi Pasteur Company Information
  57. 7.10.2 Sanofi Pasteur Business Overview
  58. 7.10.3 Sanofi Pasteur Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sanofi Pasteur Influenza Drugs Product Portfolio
  60. 7.10.5 Sanofi Pasteur Recent Developments
  61. 7.11 Protein Sciences Corporation
  62. 7.11.1 Protein Sciences Corporation Company Information
  63. 7.11.2 Protein Sciences Corporation Business Overview
  64. 7.11.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Protein Sciences Corporation Influenza Drugs Product Portfolio
  66. 7.11.5 Protein Sciences Corporation Recent Developments
  67. 7.12 Emergent Biosolutions
  68. 7.12.1 Emergent Biosolutions Company Information
  69. 7.12.2 Emergent Biosolutions Business Overview
  70. 7.12.3 Emergent Biosolutions Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Emergent Biosolutions Influenza Drugs Product Portfolio
  72. 7.12.5 Emergent Biosolutions Recent Developments
  73. 7.13 Celgene
  74. 7.13.1 Celgene Company Information
  75. 7.13.2 Celgene Business Overview
  76. 7.13.3 Celgene Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Celgene Influenza Drugs Product Portfolio
  78. 7.13.5 Celgene Recent Developments
  79. 7.14 Bristol-Myers Squibb]
  80. 7.14.1 Bristol-Myers Squibb] Company Information
  81. 7.14.2 Bristol-Myers Squibb] Business Overview
  82. 7.14.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bristol-Myers Squibb] Influenza Drugs Product Portfolio
  84. 7.14.5 Bristol-Myers Squibb] Recent Developments
  85. 7.15 BioCryst Pharmaceuticals
  86. 7.15.1 BioCryst Pharmaceuticals Company Information
  87. 7.15.2 BioCryst Pharmaceuticals Business Overview
  88. 7.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 BioCryst Pharmaceuticals Influenza Drugs Product Portfolio
  90. 7.15.5 BioCryst Pharmaceuticals Recent Developments
  91. 7.16 Alvogen
  92. 7.16.1 Alvogen Company Information
  93. 7.16.2 Alvogen Business Overview
  94. 7.16.3 Alvogen Influenza Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Alvogen Influenza Drugs Product Portfolio
  96. 7.16.5 Alvogen Recent Developments
8 North America
  1. 8.1 North America Influenza Drugs Market Size by Type
  2. 8.1.1 North America Influenza Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Influenza Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Influenza Drugs Price by Type (2021-2032)
  5. 8.2 North America Influenza Drugs Market Size by Application
  6. 8.2.1 North America Influenza Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Influenza Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Influenza Drugs Price by Application (2021-2032)
  9. 8.3 North America Influenza Drugs Market Size by Country
  10. 8.3.1 North America Influenza Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Influenza Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Influenza Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Influenza Drugs Market Size by Type
  2. 9.1.1 Europe Influenza Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Influenza Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Influenza Drugs Price by Type (2021-2032)
  5. 9.2 Europe Influenza Drugs Market Size by Application
  6. 9.2.1 Europe Influenza Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Influenza Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Influenza Drugs Price by Application (2021-2032)
  9. 9.3 Europe Influenza Drugs Market Size by Country
  10. 9.3.1 Europe Influenza Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Influenza Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Influenza Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Influenza Drugs Market Size by Type
  2. 10.1.1 China Influenza Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Influenza Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Influenza Drugs Price by Type (2021-2032)
  5. 10.2 China Influenza Drugs Market Size by Application
  6. 10.2.1 China Influenza Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Influenza Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Influenza Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Influenza Drugs Market Size by Type
  2. 11.1.1 Asia Influenza Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Influenza Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Influenza Drugs Price by Type (2021-2032)
  5. 11.2 Asia Influenza Drugs Market Size by Application
  6. 11.2.1 Asia Influenza Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Influenza Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Influenza Drugs Price by Application (2021-2032)
  9. 11.3 Asia Influenza Drugs Market Size by Country
  10. 11.3.1 Asia Influenza Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Influenza Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Influenza Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Influenza Drugs Market Size by Type
  2. 12.1.1 SAMEA Influenza Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Influenza Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Influenza Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Influenza Drugs Market Size by Application
  6. 12.2.1 SAMEA Influenza Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Influenza Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Influenza Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Influenza Drugs Market Size by Country
  10. 12.3.1 SAMEA Influenza Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Influenza Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Influenza Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Influenza Drugs Value Chain Analysis
  2. 13.1.1 Influenza Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Influenza Drugs Production Mode & Process
  6. 13.2 Influenza Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Influenza Drugs Distributors
  9. 13.2.3 Influenza Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst